Since the first generation of human induced Pluripotent Stem Cells (hiPSCs) in 2007, there has been a growing interest in these extraordinary cells, which represent a powerful tool for research and development.
trenzyme is one of our preferred service providers for cell line development and molecular biology services. The impressive level of personal customer liaison and the scientific competence are decisive factors for us to cooperate with trenzyme for many years and even to intensify in the area of demanding iPS cell line projects.
Dr. Margit Bauer & Dr. Ralf HeilkerBoehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany
Stem Cell Services FAQs
What kind of cells can be cultured, characterized or differentiated?
We work with all kind of human iPS cell lines (healthy, diseased, modified). Other stem cell types can be analyzed or differentiated on demand.
Is it possible to purchase iPSC lines or iPSC-derived progeny from trenzyme?
Although we do have internal iPSC lines and validated differentiation protocols, we do not sell these iPSC lines or iPSC-derived progeny.
Does trenzyme have validated internal differentiation protocols, which can be used to differentiated customer iPSC lines towards a special cell type?
Yes, we do have internal differentiation protocols (e.g. neuronal, or hepatocyte protocols), which can be used in order to provide customized iPSC-derived cells. You will receive the generated and cryopreserved cells, as well as a comprehensive data sheet, however, no details regarding the differentiation protocol will be given.